MyPEEPS Mobile Plus for HIV Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new mobile-based approach to prevent HIV among young men who have sex with men (YMSM). It aims to determine if the MyPEEPS Mobile app, combined with virtual guidance on using PrEP (a medication to prevent HIV), can increase PrEP use and reduce risky behaviors linked to HIV. Participants in one group will use the app and receive virtual support, while those in the other group will receive standard care information and app access. Ideal candidates are HIV-negative individuals assigned male at birth, aged 16-25, who have had condomless anal sex with a male in the past year and own a smartphone. As an unphased trial, this study offers a unique opportunity to contribute to innovative HIV prevention strategies tailored for young men.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that you cannot participate if you are currently using PrEP consistently.
What prior data suggests that this intervention is safe for improving HIV prevention outcomes in YMSM?
Research has shown that the MyPEEPS Mobile app is easy to use. It is designed to help young men who have sex with men (YMSM) reduce behaviors that increase the risk of HIV. No significant reports of negative effects have emerged from using this app, indicating its safety for users.
For the electronic PrEP peer navigation component, studies have demonstrated its effectiveness in helping individuals adhere to their PrEP (pre-exposure prophylaxis) plans. PrEP is a medication that can prevent HIV. No major safety concerns have been reported with this type of digital support.
Overall, both components of the MyPEEPS Mobile Plus approach appear safe based on previous studies.12345Why are researchers excited about this trial?
Researchers are excited about MyPEEPS Mobile for HIV prevention because it offers a unique approach by integrating a mobile application with electronic peer navigation to encourage the use of PrEP (pre-exposure prophylaxis). Unlike standard care, which typically provides information and referrals, this method leverages technology and peer support to actively engage users over a 12-month period. This combination of digital tools and personalized guidance aims to improve adherence to preventive measures, potentially making it more effective in reducing HIV risk among individuals.
What evidence suggests that MyPEEPS Mobile Plus and Electronic PrEP peer navigation could be effective for HIV prevention?
Research shows that the MyPEEPS Mobile app, available to participants in this trial, effectively provides HIV prevention information for young men who have sex with men (YMSM). Studies have found that the app is easy to use and can help reduce risky behaviors, such as having unprotected sex. Users reported fewer instances of sex without a condom, lowering the risk of contracting HIV.
Participants in the intervention arm of this trial will also receive electronic PrEP (pre-exposure prophylaxis) peer support. This support has proven effective in helping people take PrEP regularly. PrEP is a medication that helps prevent HIV. Reviews have shown that digital tools like this can help users adhere to PrEP guidelines, further reducing the risk of HIV. Together, these tools aim to increase PrEP use and improve HIV prevention among high-risk groups.12356Who Is on the Research Team?
Lisa Kuhns, PhD, MPH
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago
Robert Garofalo, MD, MPH
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago
Are You a Good Fit for This Trial?
This trial is for young men who have sex with men (YMSM), considered at high risk for HIV. Participants should be interested in using mobile technology and virtual peer support to help prevent HIV infection.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention arm will have access to the MyPEEPS mobile application and Electronic peer PrEP navigation
Control
Participants in the control arm will receive standard of care information and access to the MyPEEPS Mobile App
Follow-up
Participants are monitored for PrEP initiation, adherence, and persistence, and HIV risk behavior
What Are the Treatments Tested in This Trial?
Interventions
- Electronic PrEP peer navigation
- MyPEEPS Mobile
MyPEEPS Mobile is already approved in United States for the following indications:
- HIV prevention in young men who have sex with men (YMSM)
- HIV prevention in young transgender men and transmasculine youth
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Callen-Lorde Community Health Center
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator